This Project is Supported By:
“Field Validation of Technologies for Anaerobic Benzene and Alkylbenzene Bioremediation,” is funded through the Genome Canada Genomic Applied Partnership Program (GAPP). This project builds upon earlier research that successfully developed commercial volumes of an anaerobic benzene-degrading bioaugmentation culture and associated genomics-based monitoring tools for tracking benzene bioremediation. The goal of this project is the commercialization of an expanded range of anaerobic bioaugmentation cultures for the treatment of BTEX at contaminated sites across Canada.
Additional funding partners include the Ontario Ministry of Economic Development, Job Creation and Trade, SiREM, Imperial Oil Limited, Federated Co-operatives Limited, Alberta Innovates, and Mitacs.